Muscle progenitor cell VEGF receptor signaling in patients with peripheral arterial disease - Clinical Trial

What is the Purpose of this Study?

Treatment

We are doing this study to learn more about the differences in the muscle and blood of people that have Peripheral Arterial Disease (PAD).

What is the Condition Being Studied?
Objective

Peripheral Arterial Disease.

Who Can Participate in the Study?

Key Eligibility

- Adults with Peripheral Arterial Disease (PAD) that are:
--- Scheduled to have open vascular reconstruction, OR
--- Scheduled to undergo limb amputation due to PAD, OR
--- People who are scheduled to undergo orthopedic surgery without a diagnosis of PAD

Age Group
Adults

What is Involved?

Description

If you choose to join this study you will:
- Have muscle and tissue collected at the time of surgery and/or
- Give a blood sample at the time of surgery

Study Details

Full Title
The Role of Muscle Progenitor Cell VEGF receptor signaling in the clinical manifestations of peripheral arterial disease
Principal Investigator
Protocol Number
IRB: PRO00065709
Phase
Phase N/A
Enrollment Status
Open for Enrollment